CLINICAL STUDY ON TMS-19-Q·GC TABLET

CLINICAL STUDY ON TMS-19-Q·GC TABLET

Clinical trials on TMS-19-Q, a new synthesized macrolide antibiotic, were carried out with 10 cases of respiratory tract infection, including 2 cases of bronchitis, 4 of tonsillitis and 4 of pharyngitis. Overall clinical outcomes were excellent in 4 cases, good in 4 cases and fair in 1 case. No side...

Full description

Saved in:
Bibliographic Details
Published in:CHEMOTHERAPY Vol. 32; no. Supplement6; pp. 342 - 345
Main Authors: TAKII, MASAHIDE, KODAMA, TAKETOSHI, OTONARI, TAKATOSHI, SHIGEOKA, HIDENOBU, KUTSUKAKE, HIROSHI, SOEJIMA, HIROSHI
Format: Journal Article
Language:English
Japanese
Published: Japanese Society of Chemotherapy 1984
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Clinical trials on TMS-19-Q, a new synthesized macrolide antibiotic, were carried out with 10 cases of respiratory tract infection, including 2 cases of bronchitis, 4 of tonsillitis and 4 of pharyngitis. Overall clinical outcomes were excellent in 4 cases, good in 4 cases and fair in 1 case. No side effect was observed. This drug was considered as effective and safe for the treatment of respiratory tract infection due to Gram positive cocci, such as S. pyogenes and S. aureus.
ISSN:0009-3165
1884-5894
DOI:10.11250/chemotherapy1953.32.Supplement6_342